Literature DB >> 33172302

Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients.

Eray Metin Guler1, Mustafa Gokce2, Ahmet Bacaksiz3, Abdurrahim Kocyigit1.   

Abstract

Objective: Hypertension is a multi-factorial process prevalent in developed as well as in developing countries. Urotensin-II, different antioxidants, free radicals, and inflammatory biomarkers play an essential role in the cardiovascular system. The aim of this study is to investigate Urotensin-II, oxidative stress, and inflammation markers in normotensive, hypertensive, and resistant hypertensive patients.
Methods: Fifty resistance hypertensive (rHT) patients, 50 hypertensive patients, and 50 age gender matched normotensive controls (NT-control) were enrolled. Urotensin-II (UII), total oxidant status (TOS), total antioxidant status (TAS), native thiol (NT), total thiol (TT), disulfide (DIS), interleukin 1 beta (IL1β), interleukin 6 (IL6), tumor necrosis factor-alpha (TNFα), high sensitive c reactive protein (hsCRP), high-density lipoprotein (HDL) low-density lipoprotein (LDL), and total cholesterol (TC) were evaluated.
Results: Serum levels of UII, IL1β, IL6, TNFα, DIS, TOS, and OSI were found higher in rHT and HT as compared to NT-control (p < .001). On the contrary, serum levels of TT, TAS, and NT were lower in rHT and HT as compared to NT-control (p < .001). While TC, hsCRP, TOS, OSI, UII, IL1β, IL6, and TNFα levels increase from HT to rHT group (p < .001); TAS and NT levels decrease from HT to rHT group (p < .001). Conclusions: UII levels, oxidative stress, and inflammation are higher in rHT and HT, while antioxidants and thiol levels are lower than the NT-control. Our study clearly showed that rHT and HT are more susceptible to impaired states of antioxidants, oxidative stress, and free radicals.

Entities:  

Keywords:  Resistant hypertension; inflammation; oxidative stress; urotensin-II

Mesh:

Substances:

Year:  2020        PMID: 33172302     DOI: 10.1080/10641963.2020.1847128

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  3 in total

1.  Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid-induced skeletal muscle atrophy.

Authors:  Lin Yin; Na Li; Weihua Jia; Nuoqi Wang; Meidai Liang; Jiamin Shang; Guifen Qiang; Guanhua Du; Xiuying Yang
Journal:  Clin Transl Med       Date:  2022-05

2.  The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population.

Authors:  Marko Simunovic; Andrija Jukic; Martina Paradzik; Daniela Supe-Domic; Lada Stanisic; Marina Degoricija; Anna Hummelvoll Hillestad; Veselin Skrabic; Josko Bozic
Journal:  Children (Basel)       Date:  2022-02-04

3.  Anti-Inflammatory and Antioxidant Effects of Carvacrol on N-Methyl-N'-Nitro-N-Nitrosoguanidine (MNNG) Induced Gastric Carcinogenesis in Wistar Rats.

Authors:  Ayse Gunes-Bayir; Eray Metin Guler; Mehmet Gultekin Bilgin; Ilyas Samet Ergun; Abdurrahim Kocyigit; Agnes Dadak
Journal:  Nutrients       Date:  2022-07-12       Impact factor: 6.706

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.